[1]
L. Mantovani, P. A. Cortesi, M. Molina, L. Santoni, and L. Prosperini, “Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis”, FE, vol. 25, no. 1, Dec. 2024.